Kiran Kumar, M.D.

Chief of Lymphoma and Pediatrics Radiation Oncology Services; Program Director, Medical Residency

Associate Professor

School: Medical School
Department: Radiation Oncology

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

Education

Medical School: University of Chicago Pritzker School of Medicine (2013)
Internship: Presence Resurrection Medical Center (2014), Transitional Year
Residency: Stanford University Medical Center (2018), Radiation Oncology
Other Post Graduate Training: University of California - Berkeley (2018)
Graduate School: University of California - Berkeley (2018)

Publications

Use of PULSAR (personalized ultra-fractionated stereotactic adaptive radiotherapy) as consolidation with immune checkpoint inhibition in the treatment of pediatric metastatic melanoma: McCarty KL, Watt T, Dan TD, Timmerman RD, Kumar KA Radiation Oncology 2025 Dec 20
Vertebral fracture following primary stereotactic body radiation therapy for spinal bone metastases: a decade of experience: Chou KN, Park DJ, Sanker V, Ye X, Hori YS, Persad AR, Chuang C, Emrich SC, Ustrzynski LP, Tayag A, Kumar KA, Usoz M, Mendoza M, Rahimy E, Pollom EL, Soltys SG, Desai A, Lo CH, Chang SD Journal of neurosurgery. Spine 2025 Sep 43 294-304
Adaptive Radiation Therapy in Lymphomas: Indications, Early Experiences, and Future Directions: Kumar KA, Zhong X, Iqbal Z, Geethakumari PR, Awan FT, Yilmaz E, Wolfe H, Zahid M(, Li HC, Mallik A, Parsons D, Desai NB, Badiyan SN, Lin MH, Timmerman RD, Kozak MM International Journal of Radiation Oncology Biology Physics 2025 Jul 122 926-935
Extremity rhabdomyosarcoma in children, adolescents and young adults: A report from Children's Oncology Group trials: Oberoi S, Xue W, Qumseya A, Scharschmidt T, Binitie O, Sorger JI, Kumar KA, Wong K, Donaldson SS, Teot L, Rudzinski ER, Venkatramani R Cancer 2025 Jun 131
Impact of the Affordable Care Act and Medicaid Expansion Among Patients With HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphomas: Premnath N, Liu Y, Reves H, Pandey U, Nair RG, Anderson J, Afrough A, Anderson LD, Chung SS, Kaur G, Khan AM, Kumar KA, Madanat YF, Wolfe HR, Yilmaz E, Awan FT, Sweetenham J, Geethakumari PR JCO Oncology Practice 2025 May 21 683-693
Impact of Myc-Altered Pathology on Radiation Therapy Efficacy Among Patients With Relapsed/Refractory Large-B Cell Lymphoma: A Collaborative Study by ILROG: Tseng YD, Stevenson P, Nguyen B, Li DC, Lee DY, Paydar I, Nakashima J, Balogh A, Ravella R, Barbour AB, Post C, Ababneh H, Pinnix CC, Ballas LK, Binkley MS, Dedeckova K, Hoppe RT, Patel C, Nabavizadeh N, Kelsey CR, Kumar KA, Landsburg D, Figura NB, Lo AC, Plastaras JP International Journal of Radiation Oncology Biology Physics 2025 Apr 121 1237-1247
Second Look Opportunity for Radiation Oncology Medical Residency During Virtual Interview Season: Mahoney MT, Kwon YS, Nwachukwu CR, Iyengar P, Timmerman RD, Arbab M, Kumar KA Advances in Radiation Oncology 2025 Mar 10
Cone Beam Online Adaptive Radiation Therapy: A Promising Approach for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma?: Zhong X, Rahman M, Simmons A, Li X, Kozak M, Desai N, Timmerman R, Godley A, Cai B, Parsons D, Kumar KA, Lin MH Advances in Radiation Oncology 2025 Feb 10
Conjunction Junction, Preserve the Function: Nonoperative Management of Head and Neck Rhabdomyosarcoma: Kozak MM, Kumar KA International Journal of Radiation Oncology Biology Physics 2025 Jan 121 10-11
Single-agent rituximab and ultra-low-dose adaptive radiotherapy for the treatment of indolent B-cell non-Hodgkin lymphomas: Lake KE, Jackson M, Hull S, All S, Patel AM, Li X, Desai NB, Yilmaz E, Wolfe H, Zahid MF, Li H, Awan F, Kozak MM, Ramakrishnan Geethakumari P, Kumar KA Frontiers in Oncology 2025 15